1 S&P 500 Stock with Impressive Fundamentals and 2 That Underwhelm [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
Even among blue-chip stocks, not all investments are created equal - which is why we built StockStory to help you navigate the market. Keeping that in mind, here is one S&P 500 stock that is positioned to outperform and two that could be in trouble. Market Cap: $13.75 billion Created through the 2020 merger of Mylan and Pfizer's Upjohn division, Viatris (NASDAQ:VTRS) is a healthcare company that develops, manufactures, and distributes branded and generic medicines across more than 165 countries worldwide. Why Do We Steer Clear of VTRS? Customers postponed purchases of its products and services this cycle as its revenue declined by 4.4% annually over the last two years Earnings per share fell by 13.1% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable Negative returns on capital show management lost money while trying to expand the business, and its shrinking returns suggest its past profit sources are losing s
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris Gets FDA Nod for Generic Sandostatin, Shares Regulatory Updates [Yahoo! Finance]Yahoo! Finance
- Viatris Provides Pipeline Update on Four Regulatory MilestonesPR Newswire
- Viatris to Present at the 44th Annual J.P. Morgan Healthcare ConferencePR Newswire
- Does Viatris' Reshaping Strategy Make Sense After Recent Share Price Swings? [Yahoo! Finance]Yahoo! Finance
- Is Viatris Stock Outperforming the Dow? [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 11/6/25 - Beat
VTRS
Sec Filings
- 12/8/25 - Form 8-K
- 12/5/25 - Form 8-K
- 12/5/25 - Form 8-K/A
- VTRS's page on the SEC website